Pyridoxine HCI

Pyridoxine HCI
Product Description

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pyridoxine HCI. It belongs to vit. B6 deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A.

  • Country/Region:
    Switzerland
  • On CPHI since:
    2015
Specifications
  • Details
    Dosage: 12 mg, 25 mg.

Osmopharm S.A.

  • Country/Region:
    Switzerland
  • On CPHI since:
    2015

More Products from Osmopharm S.A. (99)

  • Phenylpropanolamine HCI

    Product Phenylpropanolamine HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenylpropanolamine HCI. It belongs to decongestant / anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.
  • Phenyltoloxamina citrate

    Product Phenyltoloxamina citrate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenyltoloxamina citrate. It belongs to antihistaminic category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.
  • Pholedrine Sulphate

    Product Pholedrine Sulphate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate. It belongs to antihypotensive (circulatory stimulant) category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.
  • Pholedrine sulphate + Norphenephrine HCI

    Product Pholedrine sulphate + Norphenephrine HCI

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate + norphenephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Piroxicam

    Product Piroxicam

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes piroxicam. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Propranolol

    Product Propranolol

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes propranolol. It belongs to antihypertensive / antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.
  • Salbutamol Sulphate

    Product Salbutamol Sulphate

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes salbutamol sulphate. It belongs to bronchodilator category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.
  • Simvastatine

    Product Simvastatine

    Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes simvastatine. It belongs to hyperlipidemia / hyperchole category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Osmopharm S.A. resources (2)